177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study. - Mandel P; Groener D; Follacchio G; Ürün Y; Bourlon MT; Sabet A; Grünwald F; Tural D; Büttner T; Kopp RM; Taha T; Chun FK; et al. (European journal of cancer (Oxford, England : 1990), 2025)